Theras: in the top 20 Champions of Growth 2020 - ITQF


Theras: in the top 20 Champions of Growth 2020 - ITQF

Theras: in the top 20 Champions of Growth 2020 - ITQF

The list of the 300 most competitive Italian companies has been released.

 In the top 20 the company based in Salsomaggiore Terme, leader in the latest generation devices for better management of diabetes and chronic pain.

 A new recognition to the company from Salsomaggiore which confirms its dynamism and growth for the three-year period 2015-2018. With this record in the industry, Theras Lifetech further strengthens its positioning as a small company in the province of Parma with annual growth exceeding 80% and a doubling of employees.


Salsomaggiore, December 2019 – The surbey carried out by the German Institute leader in market research (Itqf) highlights Theras Lifetech, a company based in Salsomaggiore just eight years ago awarded among the top 20 with the "Champions of Growth 2020 ".

From an initial list of over 10 thousand companies (most of them private, some of them listed on the stock exchange), the 300 most competitive ones were selected based on their average annual growth in the three-year period 2015-2018.


The 300 companies operate in all industries in Italy, and are mainly concentrated in the 3 most productive regions (Lombardy, Veneto and Emilia Romagna). There is a specific focus on hi-tech, generally considered to enable the highest growth rates. And both are two core features of Theras Lifetech, the company based in the province of Parma, leader in the research and marketing of cutting-edge technologies for the continuous treatment and monitoring of diabetes (80% of the business). and for the management of chronic pain (20%).


"I am very proud that our company has been included not only among the growth champions but even in the top 20 high-performance companies - comments Cristiano FERRARI, President of Theras Lifetech - Our technology offers objective advantages to patients. Thanks to the use of high-tech devices, diabetic patients can afford to "forget" about measurements and injections. And those who suffer from chronic pain can manage it better, with a much higher quality of life".


The data released at the latest edition of "Champions of Growth 2020" are very encouraging. Theras Lifetech is included in the top 20 with an average annual growth exceeding 80% and a headcount doubling in 3 years (from 14 to 34 people)


" Our staff includes employees and external collaborators as well as product specialists providing technical support to facilities, doctors and patients 24 hours a day, 7 days a week - explains Cristiano FERRARI - Every year we invest part of the turnover in Research and Development and Basic Science Research, just think of the 8 research projects in progress. The biotechnological project bound to revolutionize the treatment of post-operative pain, born from a collaboration with the CNR and the University of Parma obtained funding from the Emilia Romagna Region ".

Related news

Theras to exhibit at MEDICA in November

We will be present at MEDICA 2023, the most important international trade fair for the medical sector

Read more

Theras in Vitadio's first Board of Advisors

At the new Theras headquarters the first Board of Vitadio, a company that offers one of the world's first digital therapies

Read more

Theras will attend the Medbaltica in Riga in September

On September 21 and 22, we will be present at Medbaltica in Riga to develop new international partnerships

Read more